Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $495.97 ($4.1M) on 2026-09-17, disclosed to the SEC on 2026-09-18.
Scheduled sale ($4.1M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $495.97 | 1,579 | $783K | 19.0% |
| 2 | $496.58 | 2,873 | $1.4M | 34.5% |
| 3 | $497.54 | 1,400 | $697K | 16.9% |
| 4 | $498.74 | 843 | $420K | 10.2% |
| 5 | $499.75 | 1,160 | $580K | 14.0% |
| 6 | $500.80 | 125 |
| $63K |
| 1.5% |
| 7 | $501.58 | 320 | $161K | 3.9% |
| Total | $497.54 avg | 8,300 | $4.1M | 100% |
| Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-07-16 | $4.4M | — | Filing → |